The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Open accessAbstract
The fibrillar peptide amyloid-beta (A beta) has a chief function in the pathogenesis of Alzheimer's disease. Interleukin 1 beta (IL-1 beta) is a key cytokine in the inflammatory response to A beta. Insoluble materials such as crystals activate the inflammasome formed by the cytoplasmic receptor NALP3, which results in the release of IL-1 beta. Here we identify the NALP3 inflammasome as a sensor of A beta in a process involving the phagocytosis of A beta and subsequent lysosomal damage and release of cathepsin B. Furthermore, the IL-1 beta pathway was essential for the microglial synthesis of proinflammatory and neurotoxic factors, and the inflammasome, caspase-1 and IL-1 beta were critical for the recruitment of microglia to exogenous A beta in the brain. Our findings suggest that activation of the NALP3 inflammasome is important for inflammation and tissue damage in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Based on the previous literature42,43,46, we reasoned that cathepsin B leaking from the destabilized lysosomes may mediate the NLRP3 inflammasome activation upon SHIP1 inhibition11.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fibrillar Aβ (fAβ), following phagocytosis by microglia, activates the NLRP3 inflammasome and leads to increases in secretion of IL-1β and IL-18.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sustained elevations of IL-1β have been postulated to play a key role in AD pathogenesis [6, 12–14].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Halle et al. found that fibrillar Aβ can induce the secretion of IL-1β which depends on the presence of NLRP3.352,353”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [352]
The cited source says what the claim attributes to it.
In the citing paper
“lysosomal cathepsins, such as cathepsin B, can induce NLRP3 inflammasome activation upon leaking into the cytosol following lysosomal membrane permeabilization (LMP)42,43”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“fAβ phagocytosis results in lysosomal dysfunction and release of lysosomal contents into the cytoplasm, including the lysosomal protease cathepsin B, which is a mediator of inflammasome activation induced by Aβ [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In line with these findings, another study showed that aggregated tau seeds activated the NLRP3 inflammasome in primary mouse microglia by inducing lysosomal destabilization and release of the lysosomal protease cathepsin B, similar to fAβ [78, 82].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In parallel, reduction of SHIP1 activity is poised to disinhibit signaling pathways that are involved in the phagocytosis of Aβ, which is a required step for Aβ-induced activation of the NLRP3 inflammasome [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
In the citing paper
“Notably, Aβ also can activate NF-κB signaling and the NLRP3-ASC inflammasome [426, 427], suggesting that Aβ and tau share common mechanisms in microglia activation.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [426]
In the citing paper
“Following phagocytosis by microglia, Aβ activates the NLRP3 inflammasome leading to caspase-1 activation and IL-1β maturation and release (Halle et al., 2008).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Halle et al., 2008
In the citing paper
“Fibrillar Aβ amyloids can induce the secretion of IL-1β from microglia, via the NLRP3 inflammasome (228, 249).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“Importantly, researchers also found that ASC-, caspase-1-, IL-1 receptor-, and MyD88-deficient mice had less recruitment of microglia and mononuclear phagocytes to Aβ in the brain as compared to the wild type control after the injection of Aβ into the striatum (228).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“NLRP3 has been shown to respond to sterile stimuli, including asbestos, silica, MSU and CPPD crystals55, cholesterol crystals and β-amyloid fibrils56.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“Furthermore, there is only partial inhibition of the neutrophil infiltration and IL-1β production associated with sterile inflammation in response to cholesterol crystals44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“However, cathepsin b-deficient macrophages have no impairment in IL-1β production in response to certain NLRP3 agonists, including LPS plus ATP, or MSU crystals, despite the impairment in their response to silica44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“evidence to support this are the observations that artificial lysosomal rupture alone can activate NLRP3 and that pharmacological inhibition or genetic depletion of cathepsin b results in inhibition of caspase 1 activation, although this inhibition was only partial44,56,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“In support of this, direct treatment of ATP on primed microglia is sufficient for maturation and release of IL-1β in vitro (Halle et al, 2008) and does so via the P2X 7 receptor (Colomar et al, 2003) expressed on microglia (Monif et al, 2009).”
From Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal (2017) · cites this paper as Halle et al, 2008
In the citing paper
“In particular, microglial NLRP3 has been shown to be a major driver of amyloid beta and tau toxicity in AD, suggesting its activation has important implications for disease progression (Halle et al, 2008; Venegas et al, 2017; Ising et al, 2019).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Halle et al, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Cited by
Sorted by citations
Items 401–500 of 1,015
Martin, E., Boucher, C., Fontaine, B., & Delarasse, C. (2017) · Aging Cell · doi:10.1111/acel.12522 · Cited by 156
Amyloid‐β oligomers set fire to inflammasomes and induce Alzheimer's pathology
Salminen, A., Ojala, J. O., Suuronen, T., Kaarniranta, K., & Kauppinen, A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00496.x · Cited by 167
Proteolytic Processing of Nlrp1b Is Required for Inflammasome Activity
Frew, B. C., Joag, V., & Mogridge, J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002659 · Cited by 156
Tursi, S. A., & Tükel, Ç. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00028-18 · Cited by 171
The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer’s disease
Milner, M. T., Maddugoda, M. P., Götz, J., Burgener, S. S., & Schroder, K. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.10.011 · Cited by 162
Activation of immune signals during organ transplantation
Li, Q., & Lan, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01377-9 · Cited by 175
Jiang, Y., Wang, M., Huang, K., Zhang, Z., Shao, N., Zhang, Y., Wang, W., & Wang, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.011 · Cited by 160
Alarmins, inflammasomes and immunity
Ojcius, D. M., & Sadier, N. S. (2012) · Biomedical Journal · doi:10.4103/2319-4170.104408 · Cited by 167
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Virgilio, F. D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006171 · Cited by 168
Autophagy limits activation of the inflammasomes
Takahama, M., Akira, S., & Saitoh, T. (2017) · Immunological Reviews · doi:10.1111/imr.12613 · Cited by 163
Inflammasome activation and IL‐1β/IL‐18 processing are influenced by distinct pathways in microglia
Hanamsagar, R., Torres, V. J., & Kielian, T. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07481.x · Cited by 163
Kerur, N., Hirano, Y., Tarallo, V., Fowler, B. J., Bastos-Carvalho, A., Yasuma, T. R., Yasuma, R., Kim, Y., Hinton, D. R., Kirschning, C. J., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12500 · Cited by 163
Spectrum and Mechanisms of Inflammasome Activation by Chitosan
Bueter, C. L., Lee, C. K., Wang, J. P., Ostroff, G. R., Specht, C. A., & Levitz, S. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301695 · Cited by 161
Zhang, H., Chen, X., Zong, B., Yuan, H., Wang, Z., Wei, Y., Wang, X., Liu, G., Zhang, J., Li, S., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13743 · Cited by 158
Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158
Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease
Pennisi, M., Crupi, R., Di Paola, R., Ontario, M. L., Bella, R., Calabrese, E. J., Crea, R., Cuzzocrea, S., & Calabrese, V. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23986 · Cited by 157
Qu, Y., Ramachandra, L., Mohr, S., Franchi, L., Harding, C. V., Núñez, G., & Dubyak, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802968 · Cited by 166
He, X., Mekasha, S., Mavrogiorgos, N. C., Fitzgerald, K. A., Lien, E., & Ingalls, R. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903937 · Cited by 160
Self-citationCalabrese, V., Giordano, J., Signorile, A., Ontario, M. L., Castorina, S., Pasquale, C. D., Eckert, G. P., & Calabrese, E. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23925 · Cited by 157
Glia Crosstalk in Neuroinflammatory Diseases
Bernaus, A., Blanco, S., & Sevilla, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00209 · Cited by 157
Inflammasome activation and innate immunity in A lzheimer's disease
Heneka, M. T. (2016) · Brain Pathology · doi:10.1111/bpa.12483 · Cited by 157
The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats
Mao, Z., Liu, C., Ji, S., Yang, Q., Ye, H., Han, H., & Xue, Z. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2185-0 · Cited by 155
Morishige, T., Yoshioka, Y., Inakura, H., Tanabe, A., Yao, X., Narimatsu, S., Monobe, Y., Imazawa, T., Tsunoda, S., Tsutsumi, Y. M., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.036 · Cited by 155
Finucane, O. M., Sugrue, J. A., Rubio‐Araiz, A., Guillot‐Sestier, M., & Lynch, M. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-40619-1 · Cited by 155
Jie, F., Yang, X., Yang, B., Liu, Y., Wu, L., & Lu, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113317 · Cited by 161
Nakanishi, H., Kawashima, Y., Kurima, K., Chae, J. J., Ross, A. M., Pinto-Patarroyo, G. P., Patel, S. K., Muskett, J. A., Ratay, J. S., Chattaraj, P., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702946114 · Cited by 153
Land, W. G. (2015) · Sultan Qaboos University medical journal · doi:10.18295/2075-0528.1676 · Cited by 157
Lech, M., Avila‐Ferrufino, A., Skuginna, V., Susanti, H. E., & Anders, H. (2010) · International Immunology · doi:10.1093/intimm/dxq058 · Cited by 151
Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization
Cunha, C., Gomes, C., Vaz, A. R., & Brites, D. (2016) · Mediators of Inflammation · doi:10.1155/2016/6986175 · Cited by 153
Liu, R. T., Gao, J., Cao, S., Sandhu, N., Cui, J. Z., Chou, C. L., Fang, E., & Matsubara, J. A. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10849 · Cited by 152
The role of inflammasome-derived IL-1 in driving IL-17 responses
Mills, K. H. G., Dungan, L. S., Jones, S. A., & Harris, J. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012543 · Cited by 159
Assembly and regulation of ASC specks
Hoß, F., Rodríguez-Alcázar, J. F., & Latz, E. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2396-6 · Cited by 158
Self-citationLiu, X., Hao, W., Qin, Y., Decker, Y., Wang, X., Burkart, M., Schötz, K., Menger, M. D., Fassbender, K., & Liu, Y. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.011 · Cited by 149
A2E Induces IL-1ß Production in Retinal Pigment Epithelial Cells via the NLRP3 Inflammasome
Anderson, O. A., Finkelstein, A., & Shima, D. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067263 · Cited by 152
Dourado, N. S., Souza, C. D. S., de Almeida, M. M. A., da Silva, A. B., dos Santos, B. L., da Silva, V. D. A., de Assis, A. M., da Silva, J. S., Souza, D. O., Costa, M. D. F. D., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00119 · Cited by 159
Rosenberg, R. N., Lambracht‐Washington, D., Yu, G., & Xia, W. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0301 · Cited by 149
NLRP3 inflammasome: a promising target in ischemic stroke
Gao, L., Dong, Q., Song, Z., Shen, F., Shi, J., & Li, Y. (2016) · Inflammation Research · doi:10.1007/s00011-016-0981-7 · Cited by 150
Goldbach‐Mansky, R. T. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04533.x · Cited by 148
Sensors of the innate immune system: their mode of action
Baccalà, R., González‐Quintial, R., Lawson, B. R., Stern, M. E., Kono, D. H., Beutler, B., & Theofilopoulos, A. N. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.136 · Cited by 145
Activation of the NLRP 3 inflammasome in microglia: the role of ceramide
Scheiblich, H., Schlütter, A., Golenbock, D. T., Latz, E., Martinez‐Martinez, P., & Heneka, M. T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14225 · Cited by 147
Self-citationMicroglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
Nizami, S., Hall‐Roberts, H., Warrier, S., Cowley, S. A., & Di Daniel, E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14618 · Cited by 147
Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation
Ohto, U., Kamitsukasa, Y., Ishida, H., Zhang, Z., Murakami, K., Hirama, C., Maekawa, S., & Shimizu, T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121353119 · Cited by 152
Mulay, S. R., & Anders, H. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1601611 · Cited by 154
Ju, W., Perkins, G. A., Keun-young Kim, A., Bastola, T., Choi, W.-Y., & Choi, S. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101136 · Cited by 152
Zhang, X., Xu, A., Lv, J., Zhang, Q., Ran, Y., Wei, C., & Wu, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111822 · Cited by 148
Role of microglia in neuronal degeneration and regeneration
Walter, L. M., & Neumann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0180-5 · Cited by 144
NLRP3 Inflammasome: Key Mediator of Neuroinflammation in Murine Japanese Encephalitis
Kaushik, D. K., Gupta, M., Kumawat, K. L., & Basu, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032270 · Cited by 152
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Wang, M., Zhang, H., Liang, J., Huang, J., & Chen, N. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02753-6 · Cited by 154
The Role of the Inflammasome in Neurodegenerative Diseases
Piancone, F., La Rosa, F., Marventano, I., Saresella, M., & Clerici, M. (2021) · Molecules · doi:10.3390/molecules26040953 · Cited by 144
Vitamin B6 Prevents IL-1β Protein Production by Inhibiting NLRP3 Inflammasome Activation
Zhang, P., Tsuchiya, K., Kinoshita, T., Kushiyama, H., Suidasari, S., Hatakeyama, M., Imura, H., Katô, N., & Suda, T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.743815 · Cited by 146
Wang, R., Wang, Y., Mu, N., Lou, X., Li, W., Chen, Y., Dong, F., & Tan, H. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.30 · Cited by 144
Neuroinflammatory responses in Alzheimer’s disease
Dansokho, C., & Heneka, M. T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1831-7 · Cited by 146
Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease
Thapa, P., Upadhyay, S. P., Suo, W. Z., Singh, V., Gurung, P., Lee, E. S., Sharma, R., & Sharma, M. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104681 · Cited by 151
Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants
Olive, C. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.189 · Cited by 152
Singhrao, S. K., & Olsen, I. (2019) · Journal of Oral Microbiology · doi:10.1080/20002297.2018.1563405 · Cited by 145
NLRP3 inflammasome in ischemic stroke: As possible therapeutic target
Alishahi, M., Farzaneh, M., Ghaedrahmati, F., Nejabatdoust, A., Sarkaki, A., & Khoshnam, S. E. (2019) · International Journal of Stroke · doi:10.1177/1747493019841242 · Cited by 144
CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease
Kuemmerle-Deschner, J. B. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0491-7 · Cited by 144
Chu, J., Thomas, L. M., Watkins, S. C., Franchi, L., Núñez, G., & Salter, R. D. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0309164 · Cited by 142
Song, X., Ma, F., & Herrup, K. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0774-19.2019 · Cited by 133
Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer’s disease
Taylor, J. M., Minter, M. R., Newman, A. G., Zhang, M., Adlard, P. A., & Crack, P. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.089 · Cited by 145
Rhinovirus-Induced Calcium Flux Triggers NLRP3 and NLRC5 Activation in Bronchial Cells
Triantafilou, K., Kar, S., van Kuppeveld, F. J. M., & Triantafilou, M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0032oc · Cited by 141
Yang, M., Flavin, K., Kopf, I., Radics, G., Hearnden, C. H. A., McManus, G., Moran, B., Villalta‐Cerdas, A., Echegoyen, L. A., Giordani, S., et al. (2013) · Small · doi:10.1002/smll.201300481 · Cited by 142
Toma, C., Higa, N., Koizumi, Y., Nakasone, N., Ogura, Y., McCoy, A. J., Franchi, L., Uematsu, S., Sagara, J., Taniguchi, S., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903536 · Cited by 145
Inhibiting the Inflammasome: A Chemical Perspective
Baldwin, A. G., Brough, D., & Freeman, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01091 · Cited by 142
Hafner‐Bratkovič, I., Sušjan, P., Lainšček, D., Tapia‐Abellán, A., Cerović, K., Kadunc, L., Angosto-Bazarra, D., Pelegrı́n, P., & Jerala, R. (2018) · Nature Communications · doi:10.1038/s41467-018-07573-4 · Cited by 145
Katsnelson, M. A., Lozada‐Soto, K. M., Russo, H. M., Miller, B. A., & Dubyak, G. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00298.2015 · Cited by 141
Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases
Fenini, G., Contassot, E., & French, L. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00278 · Cited by 147
Chaurasia, S. S., Lim, R. R., Parikh, B. H., Wey, Y. S., Tun, S. B. B., Wong, T. Y., Luu, C. D., Agrawal, R. V., Ghosh, A., Mortellaro, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21198-z · Cited by 141
NLRP3 inflammasome in neurodegenerative disease
Anderson, F. L., Biggs, K. E., Rankin, B. E., & Havrda, M. C. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.006 · Cited by 154
Sterile inflammatory responses mediated by the NLRP3 inflammasome
Cassel, S. L., & Sutterwala, F. S. (2010) · European Journal of Immunology · doi:10.1002/eji.200940207 · Cited by 142
Oxidized Hemoglobin Is an Endogenous Proinflammatory Agonist That Targets Vascular Endothelial Cells
Silva, G., Jeney, V., Chora, Â., Larsen, R., Balla, J., & Soares, M. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045344 · Cited by 137
Lietzén, N., Öhman, T., Rintahaka, J., Julkunen, I., Aittokallio, T., Matikainen, S., & Nyman, T. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001340 · Cited by 137
Qin, Y., Li, M., Feng, X., Wang, J., Cao, L., Shen, X.-K., Chen, J., Sun, M., Sheng, R., Han, F., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.034 · Cited by 138
Fulp, J., Liu, H., Toldo, S. A., Jiang, Y., Boice, A., Guo, C., Li, X., Rolfe, A., Sun, D., Abbate, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00733 · Cited by 138
Huertas, A., Tu, L., Humbert, M. J. C., & Guignabert, C. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz308 · Cited by 141
P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH
Chen, S., Ma, Q., Krafft, P. R., Hu, Q., Rolland, W. B., Sherchan, P., Zhang, J., Tang, J., & Zhang, J. H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.011 · Cited by 136
Disease-associated amyloid and misfolded protein aggregates activate the inflammasome
Masters, S. L., & O'Neill, L. A. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.005 · Cited by 134
Microglia in Alzheimer's Disease: Risk Factors and Inflammation
Katsumoto, A., Takeuchi, H., Takahashi, K., & Tanaka, F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00978 · Cited by 140
Activation of NLRP 3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion
Kim, H.-Y., Kim, S., & Lee, S. (2014) · FEBS Journal · doi:10.1111/febs.13123 · Cited by 137
Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
Clayton, K. A., Enoo, A. A. V., & Ikezu, T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00680 · Cited by 137
Inflammasomes: sensors of metabolic stresses for vascular inflammation
Yang, X.-F. (2013) · Frontiers in Bioscience · doi:10.2741/4127 · Cited by 134
Mitochondria as a centrally positioned hub in the innate immune response
Sandhir, R., Halder, A., & Sunkaria, A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.10.020 · Cited by 135
Age- and location-related changes in microglial function
Ritzel, R. M., Patel, A. R., Pan, S., Crapser, J., Hammond, M., Jellison, E., & McCullough, L. D. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.016 · Cited by 134
Inflammasomes and Metabolic Disease
Henao‐Mejia, J., Elinav, E., Thaiss, C. A., & Flavell, R. A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170324 · Cited by 176
Inflammasome biology, molecular pathology and therapeutic implications
Awad, F., Assrawi, E., Louvrier, C., Jumeau, C., Georgin‐Lavialle, S., Grateau, G., Amselem, S., Giurgea, I., & Karabina, S. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.011 · Cited by 138
Mitochondria at the interface between neurodegeneration and neuroinflammation
Bader, V., & Winklhofer, K. F. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.028 · Cited by 135
NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases
Zhang, Y., Yang, W., Li, W., & Zhao, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732933 · Cited by 142
Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome
Bai, H., Yang, B., Yu, W., Xiao, Y. C., Yu, D., & Zhang, Q. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.11.015 · Cited by 138
Wang, B., Shi, J., Ge, N.-N., Ou, Z., Tian, Y., Jiang, T., Zhou, J., Xu, J. L., & Zhang, Y.-D. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1178-5 · Cited by 133
Heat-Shock Proteins in Neuroinflammation
Dukay, B., Csoboz, B., & Tóth, M. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00920 · Cited by 139
Niebler, M., Qian, X., Höfler, D., Kogosov, V., Kaewprag, J., Kaufmann, A. M., Ly, R., Böhmer, G., Zawatzky, R., Rösl, F., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003536 · Cited by 133
Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome
Mitroulis, I., Skendros, P., & Ritis, K. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.03.005 · Cited by 132
Innate Immune Response in Brain, NF-Kappa B Signaling and Cystatins
Kopitar‐Jerala, N. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00073 · Cited by 132
HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis
Swaroop, S., Sengupta, N., Suryawanshi, A. R., Adlakha, Y. K., & Basu, A. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0486-x · Cited by 135
Nanomaterial-based vaccine adjuvants
Sun, B., & Xia, T. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01131d · Cited by 136
Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
Trudler, D., Nazor, K. L., Eisele, Y. S., Grabauskas, T., Dolatabadi, N., Parker, J., Sultan, A., Zhong, Z., Goodwin, M. S., Levites, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025847118 · Cited by 137
Cyclooxygenase‐2 Regulates NLRP3 Inflammasome‐Derived IL‐1β Production
Hua, K., Chou, J., Ka, S., Tasi, Y., Chen, A., Wu, S., Chiu, H., Wong, W.-T., Wang, Y., Tsai, C., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24815 · Cited by 135
Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases
Choi, A. J. S., & Ryter, S. W. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.0104 · Cited by 132
NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens
Brodsky, I. E., & Monack, D. M. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.007 · Cited by 132
Innate instruction of adaptive immunity revisited: the inflammasome
Eisenbarth, S. C., & Flavell, R. A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900014 · Cited by 135
Metadata
- Authors
- Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- University of Freiburg (DE)
- Corresponding author
- Golenbock, Douglas T
- ORCID
- Venue
- Nature Immunology
- Published
- 2008-07-11
- Volume
- 9
- Issue
- 8
- Pages
- 857-865
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3101478
- OpenAlex
- W2119098586
- Cited by
- 2,441
- References
- 50
- Citations by year
- 2026: 92 · 2025: 124 · 2024: 143 · 2023: 165 · 2022: 191 · 2021: 188 · 2020: 169 · 2019: 151 · 2018: 136 · 2017: 139 · 2016: 138 · 2015: 146 · 2014: 149 · 2013: 153 · 2012: 98
- FWCI
- 35.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@UMassChan (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- National Institute on Aging (R01AG020255, AG20255)
- National Institute of General Medical Sciences (R37GM054060, R01GM054060, GM 54060)
- National Institute of Allergy and Infectious Diseases (AI065483, R01AI065483)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- NLRP3 inflammasome, amyloid-beta, Alzheimer's disease, innate immunity, IL-1β, caspase-1, microglia, phagocytosis, lysosomal damage, cathepsin B, neuroinflammation, neurotoxicity
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Carrier Proteins, Immunity, Innate, Inflammation, Amyloid beta-Peptides, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
